glp-1 drugs safe 🚨 Thinking about taking for weight loss? Read this first. India's drug safety authorities have issued an urgent alert asking patients, healthcare professionals, and consumers to closely MONITOR and REPORT Changes in 24-Hour Urine Single Size:15 (on the go packets)

glp-1 drugs safe 🚨 Thinking about taking for weight loss? Read this first. India's drug safety authorities have issued an urgent alert asking patients, healthcare professionals, and consumers to closely MONITOR and REPORT Changes in 24-Hour Urine Single Size:15 (on the go packets)

Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies - PMC

Scheen AJ, Lefebvre PJ

Single

Size:15 (on the go packets)

In people with obesity and established cardiovascular disease but without diabetes, semaglutide 2.4 mg resulted in 20% reduction in major adverse cardiovascular events [(MACE), death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke] compared to placebo (SELECT trial) after a mean follow-up of 39.8 months – this is the first trial demonstrating cardiovascular benefit for an obesity pharmacotherapy [110]